Analyzing the frequency and temperature dependences of the ac conductivity and dielectric analysis of reduced graphene oxide/epoxy polymer nanocomposites.

Autor: Nioua, Y.¹, El Bouazzaoui, S.¹, Melo, B.², Prezas, P.², Graça, M.², Achour, M.¹, Costa, L.², Brosseau, C.³ brosseau@univ-brest.fr

Publikováno v: Journal of Materials Science. Dec2017, Vol. 52 Issue 24, p13790-13798. 9p. 2 Charts, 8 Graphs.

Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD.

Autor: de With M; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands; Dep. of Clinical Chemistry, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., van Doorn L; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Maasland DC; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Mulder TAM; Dep. of Clinical Chemistry, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Oomen-de Hoop E; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Mostert B; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Homs MYV; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., El Bouazzaoui S; Dep. of Clinical Chemistry, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Mathijssen RHJ; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., van Schaik RHN; Dep. of Clinical Chemistry, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Bins S; Dep. of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands. Electronic address: s.bins@erasmusmc.nl.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Mar; Vol. 159, pp. 114232. Date of Electronic Publication: 2023 Jan 09.

71P Capecitabine-induced adverse events: A pharmacogenetic study beyond DPYD

Autor: De With, M., van Doorn, L., Maasland, D., Mulder, T., El Bouazzaoui, S., Mathijssen, R.H., van Schaik, R.H.N., Bins, S.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S574-S574

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.

Autor: Berends AMA; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Bolhuis MS; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Nolte IM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Buitenwerf E; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Links TP; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Timmers HJLM; Department of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Feelders RA; Department of Endocrinology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Eekhoff EMW; Department of Internal Medicine Section Endocrinology, Amsterdam University Medical Centers Location VUmc, 1117 HV Amsterdam, The Netherlands., Corssmit EPM; Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Bisschop PH; Department of Internal Medicine Section Endocrinology, Amsterdam University Medical Centers Location AMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., Haak HR; Department of Internal Medicine, Máxima Medical Center, 5504 DB Eindhoven/Veldhoven, The Netherlands.; CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht University, 6229 HX Maastricht, The Netherlands.; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Wilffert B; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.; Department of Pharmacotherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 GZ Groningen, The Netherlands., Kerstens MN; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Publikováno v: Biomedicines [Biomedicines] 2022 Apr 13; Vol. 10 (4). Date of Electronic Publication: 2022 Apr 13.

The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer.

Autor: Belderbos BPS; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de With M; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Singh RK; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Agema BC; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. s.bins@erasmusmc.nl.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Mar; Vol. 85 (3), pp. 547-553. Date of Electronic Publication: 2020 Jan 01.